BACKGROUND: We investigated whether mitogen-activated protein kinases (MAPKs) are changed in the hearts of patients with diabetes after cardioplegia and cardiopulmonary bypass (CP/CPB) operations. METHODS: Biopsies from the right atrial appendage were harvested pre- and post-CP/CPB from nondiabetic (ND) patients (n = 8, hemoglobin A1c (HbA1c) = 5.4 ± 0.12); patients with controlled diabetes (CDM) (n = 8, HbA1c = 6.5 ± 0.15); and patients with uncontrolled diabetes (UDM) (n = 8, HbA1c = 9.6 ± 0.3) undergoing coronary artery bypass grafting. The expression and/or activation of the p38-MAPK, ERK1/2, JNK, and MKP-1 in the right-atrial tissues were analyzed by Western blotting. The vasomotor function of coronary arterioles was measured by videomicroscopy. RESULTS: The post-CP/CPB levels of total p38-MAPK were decreased in the 3 groups as compared with their pre-CP/CPB levels (P < .05). There were increases in phospho-p38-MAPK, phospho-ERK1/2, and MKP-1 in UDM patients as compared with ND and CDM patients at baseline (P < .05). Compared to pre-CP/CPB, the post-CP/CPB levels of phospho-p38-MAPK decreased in the UDM group but were unaltered in the ND and CDM groups; however, the post-CP/CPB levels of phospho-p38-MAPK still remained greater than the post-CP/CPB levels of the other 2 groups. Post-CP/CPB levels of phospho-ERK1/2 were increased in the ND and CDM groups but were decreased in the UDM group compared to their pre-CP/CPB levels, respectively (P < .05). There were no significant differences in phospho-JNK in 3 groups at baseline. Post-CP/CPB levels of phospho-JNK, however, were increased in the 3 groups and were more pronounced in the myocardium of the UDM group (P < .05). After CP/CPB, the protein levels of MKP-1 were unchanged in the 3 groups when compared with their pre-CP/CPB levels. Post-CP/CPB levels of MKP-1, however, remained greater in the UDM group than in the ND and CDM groups. The post-CP/CPB contractile responses to the thromboxane A2 analog U46619 were significantly impaired in all 3 groups compared with pre-CP/CPB contractile responses. These impairments were more pronounced in the UDM group. CONCLUSION: Uncontrolled diabetes is associated with changes in expression of and activation of MAPKs and vasomotor dysfunction in the setting of CP/CPB.
BACKGROUND: We investigated whether mitogen-activated protein kinases (MAPKs) are changed in the hearts of patients with diabetes after cardioplegia and cardiopulmonary bypass (CP/CPB) operations. METHODS: Biopsies from the right atrial appendage were harvested pre- and post-CP/CPB from nondiabetic (ND) patients (n = 8, hemoglobin A1c (HbA1c) = 5.4 ± 0.12); patients with controlled diabetes (CDM) (n = 8, HbA1c = 6.5 ± 0.15); and patients with uncontrolled diabetes (UDM) (n = 8, HbA1c = 9.6 ± 0.3) undergoing coronary artery bypass grafting. The expression and/or activation of the p38-MAPK, ERK1/2, JNK, and MKP-1 in the right-atrial tissues were analyzed by Western blotting. The vasomotor function of coronary arterioles was measured by videomicroscopy. RESULTS: The post-CP/CPB levels of total p38-MAPK were decreased in the 3 groups as compared with their pre-CP/CPB levels (P < .05). There were increases in phospho-p38-MAPK, phospho-ERK1/2, and MKP-1 in UDMpatients as compared with ND and CDMpatients at baseline (P < .05). Compared to pre-CP/CPB, the post-CP/CPB levels of phospho-p38-MAPK decreased in the UDM group but were unaltered in the ND and CDM groups; however, the post-CP/CPB levels of phospho-p38-MAPK still remained greater than the post-CP/CPB levels of the other 2 groups. Post-CP/CPB levels of phospho-ERK1/2 were increased in the ND and CDM groups but were decreased in the UDM group compared to their pre-CP/CPB levels, respectively (P < .05). There were no significant differences in phospho-JNK in 3 groups at baseline. Post-CP/CPB levels of phospho-JNK, however, were increased in the 3 groups and were more pronounced in the myocardium of the UDM group (P < .05). After CP/CPB, the protein levels of MKP-1 were unchanged in the 3 groups when compared with their pre-CP/CPB levels. Post-CP/CPB levels of MKP-1, however, remained greater in the UDM group than in the ND and CDM groups. The post-CP/CPB contractile responses to the thromboxane A2 analog U46619 were significantly impaired in all 3 groups compared with pre-CP/CPB contractile responses. These impairments were more pronounced in the UDM group. CONCLUSION: Uncontrolled diabetes is associated with changes in expression of and activation of MAPKs and vasomotor dysfunction in the setting of CP/CPB.
Authors: Jun Feng; Yuhong Liu; Kamal R Khabbaz; Robert Hagberg; Michael P Robich; Richard T Clements; Cesario Bianchi; Frank W Sellke Journal: Surgery Date: 2010-08-21 Impact factor: 3.982
Authors: D Westermann; S Rutschow; S Van Linthout; A Linderer; C Bücker-Gärtner; M Sobirey; A Riad; M Pauschinger; H-P Schultheiss; C Tschöpe Journal: Diabetologia Date: 2006-08-26 Impact factor: 10.122
Authors: Jun Feng; Louis M Chu; Michael P Robich; Richard T Clements; Kamal R Khabbaz; Robert Hagberg; Yuhong Liu; Robert M Osipov; Frank W Sellke Journal: Circulation Date: 2010-09-14 Impact factor: 29.690
Authors: Jun Feng; Yuhong Liu; Louis M Chu; Richard T Clements; Kamal R Khabbaz; Michael P Robich; Cesario Bianchi; Frank W Sellke Journal: Ann Thorac Surg Date: 2011-09 Impact factor: 4.330
Authors: D Ebel; O Toma; S Appler; K Baumann; J Frässdorf; B Preckel; P Rösen; W Schlack; N C Weber Journal: Horm Metab Res Date: 2008-09-22 Impact factor: 2.936
Authors: Jun Feng; Yuhong Liu; Louis M Chu; Arun K Singh; Nikola Dobrilovic; James G Fingleton; Richard T Clements; Cesario Bianchi; Frank W Sellke Journal: Circulation Date: 2012-09-11 Impact factor: 29.690
Authors: Jun Feng; Yuhong Liu; Kamal R Khabbaz; Robert Hagberg; Neel R Sodha; Robert M Osipov; Frank W Sellke Journal: Surgery Date: 2010-01-15 Impact factor: 3.982
Authors: Allen M Andres; Kyle C Tucker; Amandine Thomas; David Jr Taylor; David Sengstock; Salik M Jahania; Reza Dabir; Somayeh Pourpirali; Jamelle A Brown; David G Westbrook; Scott W Ballinger; Robert M Mentzer; Roberta A Gottlieb Journal: JCI Insight Date: 2017-02-23